Team Careers Products Medical Affairs News Contact

Team Careers Products Medical Affairs News Contact

Back

In Vitro activity of ceftobiprole against 20,255 recent clinical bacterial isolates in Canada (CANWARD 2015-2023)

June 11, 2025

A subsidiary of Innoviva, Inc.

Innoviva is a diversified holding company with a portfolio of royalties and other healthcare assets. Learn more at inva.com

Privacy Policy | Terms of Use

Team Careers Products Medical Affairs - Report Adverse Events - Report Product Complaints News Contact

A subsidiary of Innoviva, Inc.

Innoviva is a diversified holding company with a portfolio of royalties and other healthcare assets. Learn more at inva.com

Privacy Policy | Terms of Use

© 2025 INNOVIVA SPECIALTY THERAPEUTICS | ALL RIGHTS RESERVED